CTSO

$0.00

(

0.00%

)
Quote details

stock

Cytosorbents Crp

NASDAQ | CTSO

0.84

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$57.05M

Market Cap

-

P/E Ratio

-0.18

EPS

$1.61

52 Week High

$0.71

52 Week Low

HEALTHCARE

Sector

CTSO Chart

Recent Chart
Price Action

CTSO Technicals

Tags:

CTSO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $25M
Total Revenue $36M
Cost Of Revenue $10M
Costof Goods And Services Sold $10M
Operating Income -$17M
Selling General And Administrative $35M
Research And Development $6.9M
Operating Expenses $42M
Investment Income Net -
Net Interest Income -$1.4M
Interest Income -
Interest Expense $1.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.7M
Income Before Tax -$22M
Income Tax Expense -$1.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$21M
Comprehensive Income Net Of Tax -
Ebit -$21M
Ebitda -$19M
Net Income -$21M

Revenue & Profitability

Earnings Performance

CTSO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $47M
Total Current Assets $22M
Cash And Cash Equivalents At Carrying Value $3.3M
Cash And Short Term Investments $3.3M
Inventory $2.7M
Current Net Receivables $7.3M
Total Non Current Assets $26M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $3.7M
Intangible Assets Excluding Goodwill $3.7M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $8.3M
Other Non Current Assets -
Total Liabilities $36M
Total Current Liabilities $9.8M
Current Accounts Payable $3.3M
Deferred Revenue -
Current Debt -
Short Term Debt $905K
Total Non Current Liabilities $26M
Capital Lease Obligations $13M
Long Term Debt $14M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $27M
Other Current Liabilities $5.2M
Other Non Current Liabilities -
Total Shareholder Equity $11M
Treasury Stock -
Retained Earnings -$304M
Common Stock $55K
Common Stock Shares Outstanding $54M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$14M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.8M
Capital Expenditures $284K
Change In Receivables -
Change In Inventory $500K
Profit Loss -
Cashflow From Investment -$669K
Cashflow From Financing $9.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$21M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $25M
Total Revenue $36M
Cost Of Revenue $10M
Costof Goods And Services Sold $10M
Operating Income -$17M
Selling General And Administrative $35M
Research And Development $6.9M
Operating Expenses $42M
Investment Income Net -
Net Interest Income -$1.4M
Interest Income -
Interest Expense $1.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.7M
Income Before Tax -$22M
Income Tax Expense -$1.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$21M
Comprehensive Income Net Of Tax -
Ebit -$21M
Ebitda -$19M
Net Income -$21M

CTSO News

CTSO Profile

Cytosorbents Crp Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Cytosorbents Corporation (CTSO) is at the forefront of critical care immunotherapy, pioneering advanced blood purification technologies to enhance patient outcomes in severe illnesses. Utilizing its proprietary adsorbent and porous polymer technology, the company effectively removes harmful substances from the bloodstream, addressing unmet medical needs in critical care. Headquartered in Monmouth Junction, New Jersey, Cytosorbents is strategically positioned to transform treatment options for clinicians globally, making significant strides in improving patient health and safety.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
IONQ
+7.06%
$59.37
DNN
+0.18%
$2.72
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RGTZ
-20.27%
$14.90
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
VIVK
+5.68%
$0.26
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
AMC
-0.72%
$2.73
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
MARA
+0.36%
$19.22
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
DVLT
+5.14%
$2.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
IONQ
+7.06%
$59.37
DNN
+0.18%
$2.72
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RGTZ
-20.27%
$14.90
RBNE
+7.87%
$1.37
JOBY
+1.29%
$15.67
BBD
+1.51%
$3.35
RF
-0.04%
$24.10
VIVK
+5.68%
$0.26
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
AMC
-0.72%
$2.73
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
MARA
+0.36%
$19.22
WBD
+3.50%
$21.25
ONDS
+5.56%
$7.11
DVLT
+5.14%
$2.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
NIO
+0.73%
$6.89
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
PBR
+0.93%
$11.84
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
NAKA
+10.41%
$0.79
SMR
+8.17%
$37.56

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.